Evidence map›Paper›PMID 37755828›Full record

SynthesisJAMA network open2023

Reporting of Observational Studies Explicitly Aiming to Emulate Randomized Trials: A Systematic Review.

Harrison J Hansford, Aidan G Cashin, Matthew D Jones, Sonja A Swanson, Nazrul Islam, Susan R G Douglas, Rodrigo R N Rizzo, Jack J Devonshire, Sam A Williams, Issa J Dahabreh and 14 more

Registry-linked trialAbstract readSystematic Review
In one paragraph

Synthesis in JAMA network open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07512401 (Safety of Reduced Methotrexate Lab Monitoring), which is not on this map. Cited by 52 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07512401 completednot on this map

Safety of Reduced Methotrexate Lab Monitoring: a Population-based, Target Trial Emulation Study

TypeobservationalSponsorMayo ClinicRan2012 to 2025Enrolled2,414ConditionsRheumatic DiseasesArmsStandard methotrexate lab monitoring, Reduced methotrexate lab monitoring
3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Article
  7. Active Monitoring versus Surgical Excision for Atypical Ductal Hyperplasia.Cancer prevention research (Philadelphia, Pa.) · 2026
    Observational
  8. Comparative effectiveness of posterior cervical foraminotomy versus anterior cervical discectomy with fusion for single-level cervical radiculopathy: a target trial emulation study.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Harrison J HansfordSchool of Health Sciences, Faculty of Medicine and Health, UNSW Sydney, Sydney, Australia.
Aidan G CashinSchool of Health Sciences, Faculty of Medicine and Health, UNSW Sydney, Sydney, Australia.
Matthew D JonesSchool of Health Sciences, Faculty of Medicine and Health, UNSW Sydney, Sydney, Australia.
Sonja A SwansonDepartment of Epidemiology, University of Pittsburgh, Pittsburgh, Pennsylvania.
Nazrul IslamOxford Population Health, Big Data Institute, University of Oxford, Oxford, United Kingdom.
Susan R G DouglasSchool of Health Sciences, Faculty of Medicine and Health, UNSW Sydney, Sydney, Australia.
Rodrigo R N RizzoSchool of Health Sciences, Faculty of Medicine and Health, UNSW Sydney, Sydney, Australia.
Jack J DevonshireCentre for Pain IMPACT, Neuroscience Research Australia, Sydney, Australia.
Sam A WilliamsCentre for Pain IMPACT, Neuroscience Research Australia, Sydney, Australia.
Issa J DahabrehCAUSALab, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
Barbra A DickermanCAUSALab, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
Matthias EggerInstitute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
Xabier Garcia-AlbenizDepartment of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
Robert M GolubDepartment of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Sara LodiCAUSALab, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
Margarita Moreno-BetancurClinical Epidemiology & Biostatistics Unit, Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Victoria, Australia.
Sallie-Anne PearsonSchool of Population Health, Faculty of Medicine and Health, UNSW Sydney, New South Wales, Australia.
Sebastian SchneeweissDivision of Pharmacoepidemiology, Department of Medicine, Brigham & Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Jonathan A C SterneDepartment of Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom.
Melissa K SharpDepartment of Public Health and Epidemiology, RCSI University of Medicine and Health Sciences, Dublin, Ireland.
Elizabeth A StuartDepartment of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Miguel A HernánCAUSALab, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
Hopin LeeUniversity of Exeter Medical School, Exeter, United Kingdom.
James H McAuleySchool of Health Sciences, Faculty of Medicine and Health, UNSW Sydney, Sydney, Australia.

Funding

Observational Antiretroviral Studies In Southern Africa (OASIS) CollaborationU01AI069924 · NIAID · UNIVERSITAT BERN · PI Cleophas Chimbetete, Mary-Ann Davies · 2006 to 2026
$55.9M
Translational ScienceP30AI042853 · NIAID · MIRIAM HOSPITAL · PI CURT G BECKWITH, DEBBIE M. CHENG · 1998 to 2026
$51.7M
Dynamic Strategies for the clinical management of HIV diseaseR37AI102634 · NIAID · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI MIGUEL HERNAN · 2018 to 2026
$5.3M
HIV-1 subtype-specific drug resistance in patients failing Dolutegravir-based 1st, 2nd or 3rd line regimens: the International epidemiological Databases to Evaluate AIDS (IeDEA)R01AI152772 · NIAID · UNIVERSITY OF ZURICH · PI Roger Dimitri Kouyos · 2021 to 2026
$3.2M
Identifying optimal dynamic strategies for prostate cancer controlR00CA248335 · NCI · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI DICKERMAN, BARBRA ANNE · 2022 to 2025
$688k
NCI NIH HHS R00 CA248335NIAID NIH HHS P30 AI042853NIAID NIH HHS R01 AI152772NIAID NIH HHS R37 AI102634NIAID NIH HHS U01 AI069924
6 · The paper itself

Abstract

Importance: Observational (nonexperimental) studies that aim to emulate a randomized trial (ie, the target trial) are increasingly informing medical and policy decision-making, but it is unclear how these studies are reported in the literature. Consistent reporting is essential for quality appraisal, evidence synthesis, and translation of evidence to policy and practice. Objective: To assess the reporting of observational studies that explicitly aimed to emulate a target trial. Evidence Review: We searched Medline, Embase, PsycINFO, and Web of Science for observational studies published between March 2012 and October 2022 that explicitly aimed to emulate a target trial of a health or medical intervention. Two reviewers double-screened and -extracted data on study characteristics, key predefined components of the target trial protocol and its emulation (eligibility criteria, treatment strategies, treatment assignment, outcome[s], follow-up, causal contrast[s], and analysis plan), and other items related to the target trial emulation. Findings: A total of 200 studies that explicitly aimed to emulate a target trial were included. These studies included 26 subfields of medicine, and 168 (84%) were published from January 2020 to October 2022. The aim to emulate a target trial was explicit in 70 study titles (35%). Forty-three studies (22%) reported use of a published reporting guideline (eg, Strengthening the Reporting of Observational Studies in Epidemiology). Eighty-five studies (43%) did not describe all key items of how the target trial was emulated and 113 (57%) did not describe the protocol of the target trial and its emulation. Conclusion and Relevance: In this systematic review of 200 studies that explicitly aimed to emulate a target trial, reporting of how the target trial was emulated was inconsistent. A reporting guideline for studies explicitly aiming to emulate a target trial may improve the reporting of the target trial protocols and other aspects of these emulation attempts.

Indexed as

Observational Studies as TopicRandomized Controlled Trials as Topic

Identifiers

PMID37755828
PMCPMC10534275

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.